Skip to main content
You have permission to edit this article.
Edit
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Apyx Medical Corp (NQ: APYX )

4.675 +0.125 (+2.75%)
Streaming Delayed Price Updated: 12:26 PM EDT, Sep 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 74,952
Open 4.630
Bid (Size) 4.650 (3)
Ask (Size) 4.700 (2)
Prev. Close 4.550
Today's Range 4.560 - 4.800
52wk Range 3.010 - 17.50
Shares Outstanding 34,322,749
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Friday, 9/23, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2022 Financial Results on November 10, 2022
From Apyx Medical Corporation
Via Business Wire

Performance

YTD
-64.39%
-64.39%
1 Month
-20.49%
-20.49%
3 Month
-24.96%
-24.96%
6 Month
-33.31%
-33.31%
1 Year
-66.25%
-66.25%

More News

Read More
Looking Into Apyx Medical's Return On Capital Employed
Via Benzinga
Apyx Medical Corporation to Participate in the Lake Street Best Ideas Growth Conference
From Apyx Medical Corporation
Via Business Wire
Apyx Medical: Q2 Earnings Insights
Via Benzinga
Apyx Medical's Renuvion Scores FDA Approval To Eliminate Sagging Neck
Via Benzinga
Apyx Medical Posts Encouraging Data From Renuvion Device In Sagging Skin
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
Via Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Via Benzinga
Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Reminds Apyx Medical Corporation (APYX) Investors of Class Action and Last Few Hours to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medical Corporation (APYX)
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
APYX DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
APYX FINAL DEADLINE ALERT: GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Apyx Medical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 5 Deadline in Securities Class Action - APYX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
APYX DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Apyx Medical Corporation Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action – APYX
From Rosen Law Firm
Via Business Wire
Apyx Medical Corporation Releases Environmental, Social and Governance Data in New Tear Sheet
From Apyx Medical Corporation
Via Business Wire
APYX FINAL DEADLINE ALERT: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 5 Deadline in Securities Class Action - APYX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Recap of Monday's Biotech Catalysts - End of the Day Summary
Via Benzinga
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Improve Appearance of Lax (Loose) Skin
From Apyx Medical Corporation
Via Business Wire
APYX INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APYX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Apyx Medical Corporation Announces Results of the U.S. IDE Clinical Study Evaluating the Use of Renuvion to Improve the Appearance of Lax Skin in the Neck and Submental Region
From Apyx Medical Corporation
Via Business Wire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - APYX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.